In ccRCC, development of xenografts with mutated pVHL has been shown to require HIF-α activity [39, 40], and HIF-1 pathway upregulation suppressed biosynthesis of mitochondria [41, 42]. The gene discussed is HIF1A; the disease is nonpapillary renal cell carcinoma.